HY-136409-10mg
|
MedChemexpress LLC
|
N-Decanoyl-L-homoserine lactone [CAS 177315-87-6]
|
|
COVID-19-immunoregulation
|
|
HY-136409-100mg
|
MedChemexpress LLC
|
N-Decanoyl-L-homoserine lactone [CAS 177315-87-6]
|
|
COVID-19-immunoregulation
|
|
HY-136409-25mg
|
MedChemexpress LLC
|
N-Decanoyl-L-homoserine lactone [CAS 177315-87-6]
|
|
COVID-19-immunoregulation
|
|
HY-136409-5mg
|
MedChemexpress LLC
|
N-Decanoyl-L-homoserine lactone [CAS 177315-87-6]
|
|
COVID-19-immunoregulation
|
|
HY-136409-50mg
|
MedChemexpress LLC
|
N-Decanoyl-L-homoserine lactone [CAS 177315-87-6]
|
|
COVID-19-immunoregulation
|
|
HY-14956S-1mg
|
MedChemexpress LLC
|
Nemonoxacin-d3
|
|
COVID-19-immunoregulation
|
|
HY-14956S-5mg
|
MedChemexpress LLC
|
Nemonoxacin-d3
|
|
COVID-19-immunoregulation
|
|
HY-P1607-1g
|
MedChemexpress LLC
|
Nisin [CAS 1414-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-P1607-100mg
|
MedChemexpress LLC
|
Nisin [CAS 1414-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-P1607-5g
|
MedChemexpress LLC
|
Nisin [CAS 1414-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-P1607-500mg
|
MedChemexpress LLC
|
Nisin [CAS 1414-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-144223-10mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-2 [CAS 791840-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-144223-100mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-2 [CAS 791840-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-144223-25mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-2 [CAS 791840-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-144223-5mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-2 [CAS 791840-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-144223-50mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-2 [CAS 791840-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-144223-1mL
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-2 [CAS 791840-86-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-144226-10mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-3 [CAS 1787787-60-3]
|
|
COVID-19-immunoregulation
|
|
HY-144226-100mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-3 [CAS 1787787-60-3]
|
|
COVID-19-immunoregulation
|
|
HY-144226-25mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-3 [CAS 1787787-60-3]
|
|
COVID-19-immunoregulation
|
|
HY-144226-5mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-3 [CAS 1787787-60-3]
|
|
COVID-19-immunoregulation
|
|
HY-144226-50mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-3 [CAS 1787787-60-3]
|
|
COVID-19-immunoregulation
|
|
HY-144226-1mL
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-3 [CAS 1787787-60-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-146086-10mg
|
MedChemexpress LLC
|
Nrf2 activator-4 [CAS 2383016-68-8]
|
|
COVID-19-immunoregulation
|
|
HY-146086-100mg
|
MedChemexpress LLC
|
Nrf2 activator-4 [CAS 2383016-68-8]
|
|
COVID-19-immunoregulation
|
|